Morgan Stanley (NYSE:MS) analyst Jeffrey Hung upgraded Cytokinetics (NASDAQ:CYTK) stock from Equalweight to Overweight, while ...

It's worth noting that Microsoft isn't a cheap stock. Even after this move, Microsoft trades for about 30.5 times forward ...

If you own a computer, you know of Microsoft Windows. In fact, it's the most widely used operating system in the world, with ...

Microsoft (NASDAQ:MSFT) has delivered minimal gains over the past year and it has actually declined 1.61% year-to-date. This ...

Sales of an Alzheimer’s disease treatment were better than expected, but that and a quarterly beat wasn’t enough to offset ...

Microsoft (NASDAQ: MSFT) has been on a winning streak for decades now. One of the biggest tech companies in the world, it's ...

Microsoft stock has been a millionaire maker for decades, with a stock split-adjusted IPO price of $0.14, which means at today’s stock price of $423.39, the stock is up 435038.85%. That would ...

Microsoft reported its fiscal second-quarter results after Wednesday's closing bell, with investors focused on all things AI.

The S&P 500 will trade in a range that implies the index dropping as much as 8% or rising a little over 1% in the coming ...

Microsoft's stock is undervalued by around 10% based on DCF analysis, and Wall Street analysts see even greater upside potential. Aggressive innovation and substantial AI data center investments ...

The Fed made the right call in hitting pause this week. "I'm not sure that pausing is really all the bad for stocks in the ...